A Prospective Phase III Randomized Trial of Hypofractionation Versus Conventional Fractionation in Patients With High-Risk Prostate Cancer
Authors:
- Giorgio ArcangeliGAGiorgio Arcangeli
- Biancamaria SaracinoBSBiancamaria Saracino
- Sara GomelliniSGSara Gomellini
- Maria Grazia PetrongariMPMaria Grazia Petrongari
- Stefano ArcangeliSAStefano Arcangeli
- Steno SentinelliSSSteno Sentinelli
- Simona MarziSMSimona Marzi
- Valeria LandoniVLValeria Landoni
- Jack FowlerJFJack Fowler
- Lidia StrigariLSLidia Strigari
- 1 September 2010
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 78 (1) , 11-18
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Long-Term Results of Conformal Radiotherapy for Prostate Cancer: Impact of Dose Escalation on Biochemical Tumor Control and Distant Metastases-Free Survival OutcomesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase III randomized trialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: Report on acute toxicityRadiotherapy and Oncology, 2006
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 GyJournal of Clinical Oncology, 2006
- Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate CancerJournal of Clinical Oncology, 2005
- Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Is α/β for prostate tumors really low?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Late effects toxicity scoring: The soma scaleInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995